03/06/2025
9:52 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/18/2025
5:07 AM | Revance Therapeutics (Filer)
| Form 15-12G | |
02/12/2025
6:57 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
6:58 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:00 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:01 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:02 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:03 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:04 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:06 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
7:08 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for RVNC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revance Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/12/2025
7:16 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
6:50 AM | Revance Therapeutics (Filer)
| Form POSASR | |
02/12/2025
6:52 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
6:53 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
6:54 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/12/2025
6:55 AM | Revance Therapeutics (Filer)
| Form S-8 POS | |
02/11/2025
11:16 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:06 PM | Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
5:19 PM | GLAZER CAPITAL, LLC (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025
2:45 PM | Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
2:48 PM | Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
2:49 PM | Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
2:49 PM | Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
8:22 AM | Nasdaq Stock Market LLC (Filed by)
Revance Therapeutics (Subject)
| Form 25-NSE | |
02/06/2025
7:59 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:53 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:53 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:53 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:41 AM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
02/05/2025
7:14 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
01/31/2025
7:08 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
01/31/2025
6:46 AM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/30/2025
8:01 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SCHEDULE 13D/A | |
01/21/2025
7:31 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
01/21/2025
7:36 AM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/21/2025
7:11 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
7:15 AM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/13/2025
3:18 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/13/2025
7:44 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
01/10/2025
3:52 PM | Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
01/07/2025
8:02 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/06/2025
8:00 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
3:34 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:36 PM | Revance Therapeutics (Subject)
| Form SC 14D9/A | |
01/02/2025
3:45 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T/A | |
12/19/2024
8:00 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SCHEDULE 13D/A | |
12/12/2024
7:01 AM | Revance Therapeutics (Subject)
| Form SC 14D9 | |
12/12/2024
6:15 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-T | |
12/12/2024
5:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
4:16 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
12/09/2024
8:24 AM | Revance Therapeutics (Subject)
| Form SC14D9C | |
12/09/2024
8:17 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:23 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:27 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:02 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
8:24 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
12:20 PM | FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
10/25/2024
7:49 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
6:17 PM | GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
10/18/2024
8:29 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
9:08 AM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
6:32 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
6:15 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:01 PM | Beryl Capital Management LLC (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G | |
09/09/2024
9:40 AM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
09/05/2024
4:27 PM | Revance Therapeutics (Subject)
| Form SC14D9C | |
09/05/2024
3:45 PM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
08/13/2024
8:29 AM | Crown Laboratories, Inc. (Filed by)
Revance Therapeutics (Subject)
| Form SC TO-C | |
08/12/2024
4:18 PM | Revance Therapeutics (Subject)
| Form SC14D9C | |
08/12/2024
8:20 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
8:00 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:34 PM | Revance Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/02/2024
4:47 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:47 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:08 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
7:42 AM | Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:43 AM | Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:44 AM | Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:45 AM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:46 AM | Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:47 AM | Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
7:47 AM | Revance Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy RVNC Stock Free RVNC Stock Alerts